Cargando…
Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019–2020? A cross-sectional study in ClinicalTrials.gov
OBJECTIVES: Decentralised clinical trial activities—such as participant recruitment via social media, data collection through wearables and direct-to-participant investigational medicinal product (IMP) supply—have the potential to change the way clinical trials (CTs) are conducted and with that to r...
Autores principales: | de Jong, Amos J, Grupstra, Renske J, Santa-Ana-Tellez, Yared, Zuidgeest, Mira G P, de Boer, Anthonius, Gardarsdottir, Helga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438113/ https://www.ncbi.nlm.nih.gov/pubmed/36038171 http://dx.doi.org/10.1136/bmjopen-2022-063236 |
Ejemplares similares
-
Implementation status and consideration for the globalisation of decentralised clinical trials: a cross-sectional analysis of clinical trial databases
por: Sato, Takahiro, et al.
Publicado: (2023) -
COVID‐19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European Union
por: de Jong, Amos Jochanan, et al.
Publicado: (2021) -
Characteristics of Depression Clinical Trials Registered on ClinicalTrials.gov
por: Liang, Juan, et al.
Publicado: (2022) -
Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective
por: de Jong, Amos J., et al.
Publicado: (2022) -
Registration of phase 3 crossover trials on ClinicalTrials.gov
por: Zeng, Lijuan, et al.
Publicado: (2020)